Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Sep;76(3):1243–1251. doi: 10.1172/JCI112080

Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.

F Caligaris-Cappio, L Bergui, L Tesio, G Pizzolo, F Malavasi, M Chilosi, D Campana, B van Camp, G Janossy
PMCID: PMC424031  PMID: 2931452

Abstract

Precursors of plasma cells were studied in the bone marrow of 28 patients with multiple myeloma, plasma cell leukemia, and benign monoclonal gammopathy. Pre-B and B cell populations were analyzed with anti-B monoclonal antibodies corresponding to the clusters standardized at the Leucocyte Typing Workshops in Paris and Boston (CD9, CD10, CD19-22, CD24). In advanced forms of plasma cell malignancies, such as cases of multiple myeloma in stages II and III and of plasma cell leukemia, some cells of lymphoid morphology expressed common acute lymphoblastic leukemia antigen (CALLA, CD10) and HLA-DR, but contained no detectable terminal deoxynucleotidyl transferase enzyme. These CALLA+ cells were absent in benign monoclonal gammopathies. In multiple myeloma, the CALLA+ cells were negative for surface and cytoplasmic immunoglobulins (Ig), and, unlike CALLA+, terminal deoxynucleotidyl transferase (TdT+) pre-B cells in the normal bone marrow also failed to react with antibodies to B cell-associated antigens such as CD9, CD19, CD22, and CD24. The CALLA+, Ig- cells could be regarded as preplasmacytic since, after having been separated and stimulated with the phorbol ester 12-0-tetradecanoyl-phorbol-13 acetate in vitro, they transformed into plasma cells and synthesized the same heavy and light chains as myeloma cells.

Full text

PDF
1243

Images in this article

1246Image
on p.1246
1247Image
on p.1247
1247Image
on p.1247
1247Image
on p.1247
1247Image
on p.1247
1248Image
on p.1248
1248Image
on p.1248
1248Image
on p.1248
1248Image
on p.1248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson C. S., Kersey J. H., LeBien T. W. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol. 1981 Jan;126(1):83–88. [PubMed] [Google Scholar]
  2. Bodger M. P., Janossy G., Bollum F. J., Burford G. D., Hoffbrand A. V. The ontogeny of terminal deoxynucleotidyl transferase positive cells in the human fetus. Blood. 1983 Jun;61(6):1125–1131. [PubMed] [Google Scholar]
  3. Brouet J. C., Preud'homme J. L., Penit C., Valensi F., Rouget P., Seligmann M. Acute lymphoblastic leukemia with pre-B-cell characteristics. Blood. 1979 Jul;54(1):269–273. [PubMed] [Google Scholar]
  4. Caligaris-Cappio F., Janossy G., Campana D., Chilosi M., Bergui L., Foà R., Delia D., Giubellino M. C., Preda P., Gobbi M. Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res. 1984;8(4):567–578. doi: 10.1016/0145-2126(84)90005-5. [DOI] [PubMed] [Google Scholar]
  5. Campana D., Janossy G., Bofill M., Trejdosiewicz L. K., Ma D., Hoffbrand A. V., Mason D. Y., Lebacq A. M., Forster H. K. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol. 1985 Mar;134(3):1524–1530. [PubMed] [Google Scholar]
  6. Cossman J., Neckers L. M., Arnold A., Korsmeyer S. J. Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med. 1982 Nov 11;307(20):1251–1254. doi: 10.1056/NEJM198211113072006. [DOI] [PubMed] [Google Scholar]
  7. Drewinko B., Alexanian R., Boyer H., Barlogie B., Rubinow S. I. The growth fraction of human myeloma cells. Blood. 1981 Feb;57(2):333–338. [PubMed] [Google Scholar]
  8. Durant J. R., Barry W. E., Learner N. The changing face of myeloma. Lancet. 1966 Jan 15;1(7429):119–121. doi: 10.1016/s0140-6736(66)91259-1. [DOI] [PubMed] [Google Scholar]
  9. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  10. Falini B., De Solas I., Levine A. M., Parker J. W., Lukes R. J., Taylor C. R. Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases. Blood. 1982 May;59(5):923–933. [PubMed] [Google Scholar]
  11. Garewal H., Durie B. G. Aggressive phase of multiple myeloma with pulmonary cell infiltrates. JAMA. 1982 Oct 15;248(15):1875–1876. [PubMed] [Google Scholar]
  12. Gobbi M., Caligaris-Cappio F., Campana D., Tazzari P. L., Bergui L., Cavo M., Tura S. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Clin Exp Immunol. 1984 Dec;58(3):625–630. [PMC free article] [PubMed] [Google Scholar]
  13. Gobbi M., Caligaris-Cappio F., Janossy G. Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies. Br J Haematol. 1983 Jul;54(3):393–403. doi: 10.1111/j.1365-2141.1983.tb02114.x. [DOI] [PubMed] [Google Scholar]
  14. Greaves M. F., Hariri G., Newman R. A., Sutherland D. R., Ritter M. A., Ritz J. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood. 1983 Apr;61(4):628–639. [PubMed] [Google Scholar]
  15. Greaves M., Verbi W., Vogler L., Cooper M., Ellis R., Ganeshaguru K., Hoffbrand V., Janossy G., Bollum F. J. Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia. Leuk Res. 1979;3(6):353–362. doi: 10.1016/0145-2126(79)90032-8. [DOI] [PubMed] [Google Scholar]
  16. Halper J., Fu S. M., Wang C. Y., Winchester R., Kunkel H. G. Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol. 1978 May;120(5):1480–1484. [PubMed] [Google Scholar]
  17. Hamburger A., Salmon S. E. Primary bioassay of human myeloma stem cells. J Clin Invest. 1977 Oct;60(4):846–854. doi: 10.1172/JCI108839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hobbs J. R. Monitoring myelomatosis. Arch Intern Med. 1975 Jan;135(1):125–130. [PubMed] [Google Scholar]
  19. Hokland P., Nadler L. M., Griffin J. D., Schlossman S. F., Ritz J. Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood. 1984 Sep;64(3):662–666. [PubMed] [Google Scholar]
  20. Holt J. M., Robb-Smith A. H. Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy. J Clin Pathol. 1973 Sep;26(9):649–659. doi: 10.1136/jcp.26.9.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Janossy G., Bollum F. J., Bradstock K. F., McMichael A., Rapson N., Greaves M. F. Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol. 1979 Oct;123(4):1525–1529. [PubMed] [Google Scholar]
  22. Janossy G., Roberts M., Greaves M. F. Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia. Lancet. 1976 Nov 13;2(7994):1058–1061. doi: 10.1016/s0140-6736(76)90970-3. [DOI] [PubMed] [Google Scholar]
  23. Karpas A., Fischer P., Swirsky D. Human myeloma cell line carrying a Philadelphia chromosome. Science. 1982 May 28;216(4549):997–999. doi: 10.1126/science.7079750. [DOI] [PubMed] [Google Scholar]
  24. Kersey J. H., LeBien T. W., Abramson C. S., Newman R., Sutherland R., Greaves M. P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med. 1981 Mar 1;153(3):726–731. doi: 10.1084/jem.153.3.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Knapp W., Majdic O., Bettelheim P., Liszka K. VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells. Leuk Res. 1982;6(2):137–147. doi: 10.1016/0145-2126(82)90019-4. [DOI] [PubMed] [Google Scholar]
  26. Korsmeyer S. J., Arnold A., Bakhshi A., Ravetch J. V., Siebenlist U., Hieter P. A., Sharrow S. O., LeBien T. W., Kersey J. H., Poplack D. G. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983 Feb;71(2):301–313. doi: 10.1172/JCI110770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lynch R. G., Rohrer J. W., Odermatt B., Gebel H. M., Autry J. R., Hoover R. G. Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation. Immunol Rev. 1979;48:45–80. doi: 10.1111/j.1600-065x.1979.tb00298.x. [DOI] [PubMed] [Google Scholar]
  28. Malavasi F., Caligaris-Cappio F., Milanese C., Dellabona P., Richiardi P., Carbonara A. O. Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol. 1984 Jan;9(1):9–20. doi: 10.1016/0198-8859(84)90003-x. [DOI] [PubMed] [Google Scholar]
  29. Minowada J., Janossy G., Greaves M. F., Tsubota T., Srivastava B. I., Morikawa S., Tatsumi E. Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst. 1978 Jun;60(6):1269–1277. doi: 10.1093/jnci/60.6.1269. [DOI] [PubMed] [Google Scholar]
  30. Moir D. J., Ghosh A. K., Abdulaziz Z., Knight P. M., Mason D. Y. Immunoenzymatic staining of haematological samples with monoclonal antibodies. Br J Haematol. 1983 Nov;55(3):395–410. doi: 10.1111/j.1365-2141.1983.tb02154.x. [DOI] [PubMed] [Google Scholar]
  31. Nadler L. M., Anderson K. C., Marti G., Bates M., Park E., Daley J. F., Schlossman S. F. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol. 1983 Jul;131(1):244–250. [PubMed] [Google Scholar]
  32. Nadler L. M., Korsmeyer S. J., Anderson K. C., Boyd A. W., Slaughenhoupt B., Park E., Jensen J., Coral F., Mayer R. J., Sallan S. E. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest. 1984 Aug;74(2):332–340. doi: 10.1172/JCI111428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nadler L. M., Ritz J., Bates M. P., Park E. K., Anderson K. C., Sallan S. E., Schlossman S. F. Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia. J Clin Invest. 1982 Aug;70(2):433–442. doi: 10.1172/JCI110633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Okano H., Azar H. A., Osserman E. F. Plasmacytic reticulum cell sarcoma. Case report with electron microscopic studies. Am J Clin Pathol. 1966 Nov;46(5):546–555. doi: 10.1093/ajcp/46.5.546. [DOI] [PubMed] [Google Scholar]
  35. Pileri A., Tarocco R. P. In vivo kinetic studies in human myeloma. Haematologica. 1974 Mar;59(1):10–24. [PubMed] [Google Scholar]
  36. Ritz J., Pesando J. M., Notis-McConarty J., Lazarus H., Schlossman S. F. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature. 1980 Feb 7;283(5747):583–585. doi: 10.1038/283583a0. [DOI] [PubMed] [Google Scholar]
  37. Ruiz-Argüelles G. J., Katzmann J. A., Greipp P. R., Gonchoroff N. J., Garton J. P., Kyle R. A. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood. 1984 Aug;64(2):352–356. [PubMed] [Google Scholar]
  38. Sahasrabudhe D. M., Parker J. C. Decreasing M spike with increasing tumor burden in multiple myeloma. Arch Intern Med. 1981 Aug;141(9):1152–1153. [PubMed] [Google Scholar]
  39. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed] [Google Scholar]
  40. Suchman A. L., Coleman M., Mouradian J. A., Wolf D. J., Saletan S. Aggressive plasma cell myeloma. A terminal phase. Arch Intern Med. 1981 Sep;141(10):1315–1320. [PubMed] [Google Scholar]
  41. Taylor C. R., Russell R., Chandor S. An immunohistologic study of multiple myeloma and related conditions, using an immunoperoxidase method. Am J Clin Pathol. 1978 Oct;70(4):612–622. doi: 10.1093/ajcp/70.4.612. [DOI] [PubMed] [Google Scholar]
  42. Van Den Berghe H., Louwagie A., Broeckaert-Van Orshoven A., David G., Verwilghen R., Michaux J. L., Sokal G. Philadelphia chromosome in human multiple myeloma. J Natl Cancer Inst. 1979 Jul;63(1):11–16. [PubMed] [Google Scholar]
  43. Vogler L. B., Crist W. M., Bockman D. E., Pearl E. R., Lawton A. R., Cooper M. D. Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. N Engl J Med. 1978 Apr 20;298(16):872–878. doi: 10.1056/NEJM197804202981603. [DOI] [PubMed] [Google Scholar]
  44. Warner T. F., Moses H. L., Fair D. S., Krueger R. G. Circulating tumor cells in murine myeloma. J Natl Cancer Inst. 1977 Apr;58(4):983–992. doi: 10.1093/jnci/58.4.983. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES